Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver
Alexander, H.R.; Bartlett, D.L.; Libutti, S.K.
Cancer Journal From Scientific American 4(1): 2-11
1998
ISSN/ISBN: 1081-4442 PMID: 9467038 Document Number: 486561
Document emailed within 1 workday
Related Documents
Szakacs, J.G.; Szakacs, J.E.; Karl, R.C. 1990: Surgical resection versus perfusion in the treatment of metastatic and primary liver tumors Annals of Clinical and Laboratory Science 20(4): 245-257Papachristou, D.N.; Fortner, J.J. 1983: Surgical treatment of metastatic melanoma confined to the liver International Surgery 68(2): 145-148
Hu, M.; Li, M.-H.; Kong, L.; Liu, N.-B.; Yang, G.-R.; Yu, J.-M. 2008: (18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin Zhonghua Zhong Liu Za Zhi 30(9): 699-701
De Brauw, L.M.; Marinelli, A.; van de Velde, C.J.; Hermans, J.; Tjaden, U.R.; Erkelens, C.; de Bruijn, E.A. 1991: Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil Cancer Research 51(6): 1694-1700
Borisov, A.E.; Gershanovich, M.L.; Zemlianoĭ, V.P.; Nepomniashchaia, S.L.; Stukov, A.N.; Filov, V.A. 1998: The use of dioxadet in chemoembolization of the hepatic artery in primary and metastatic cancer of the liver Voprosy Onkologii 44(6): 714-717
Tezuka, T.; Shinohara, K.; Miura, T.; Takagi, S.; Murata, M.; Seki, M. 1992: Intra-arterial infusion chemotherapy with side-hole catheter for primary and metastatic liver, bile duct, and pancreas cancers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1572-1575
Yoshida, T.; Kido, M.; Fukumoto, T.; Komatsu, S.; Takahashi, M.; Takebe, A.; Tanaka, M.; Kuramitsu, K.; Kinoshita, H.; Ajiki, T.; Matsumoto, I.; Shinzeki, M.; Okazaki, T.; Asari, S.; Ku, Y. 2013: The role of preoperative percutaneous isolated hepatic perfusion and hepatectomy in multidisciplinary treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1822-1824
Isshiki, K.; Nonami, T.; Kishimoto, W.; Katoh, H.; Akaza, K.; Harada, A.; Nakao, A.; Takagi, H. 1990: Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(8 Part 2): 1634-1637
Schwemmle, K. 1971: The treatment of hepatic coma with heterologous perfusion of pig's liver Münchener Medizinische Wochenschrift 113(14): 519-523
Korovin, S.I.; Tolstopiatov, B.A.; Medinets, I.R.; Protsenko, V.V.; Dedkov, A.G.; Palivets, A.I.; Smakova, M.S. 2002: Use of local magnitothermia in the treatment of patients with primary-confined skin melanoma Likars'ka Sprava 1: 129-133
Králík, J.; Koranda, P.; Neoral, C.; Grosmanová, T.; Jezdinská, V.; Utíkal, P.; Klementa, I. 1993: Experimental verification of the hepatic perfusion index for monitoring direct liver perfusion by portal blood Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 72(5): 212-215
Bioulac-Sage, P.; Boulard, A.; Rossignol, D.; Bernard, P.; Le Bail, B.; Quinton, A.; Balabaud, C. 1988: The increase in the number of liver sinusoidal pit cells in four patients with primary or metastatic cancer of the liver Journal of Submicroscopic Cytology and Pathology 20(2): 335-340
Cetrullo, C.; Di Nino, G.F.; Faenza, S.; Melotti, R.; Spartà, S. 1978: Crossed perfusion with heterologous liver in the treatment of hepatic coma. Clinical experience Minerva Anestesiologica 44(3): 171-178
Csiffáry, D.; Oszvald, P.; Vas, G. 1970: Treatment of hepatic coma with extracorporeal perfusion of porcine liver (preliminary report) Orvosi Hetilap 111(11): 615-616
Lou, M.-w.; Wang, H.; Gao, T.-j.; Fan, Y. 2010: A preliminary clinical study on the treatment of primary hepatic carcinoma by transcatheter arterial perfusion of batroxobin combined with TACE Zhonghua Zhong Liu Za Zhi 32(5): 373-376
Hoffman, A.L.; Wu, S.S.; Obaid, A.K.; French, S.W.; Lois, J.; McMonigle, M.; Ramos, H.C.; Sher, L.S.; Lopez, R.R. 2002: Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors American Surgeon 68(12): 1038-1043
Peretz, T.; Freund, H.R.; Isacson, R.; Ben-Yosef, A.; Goldin, E.; Haskel, L.; Chisin, R.; Biran, S.; Durst, A.L. 1988: Treatment of primary and metastatic liver cancer using an implantable chemoinfusion pump Israel Journal of Medical Sciences 24(9-10): 562-567
Fraker, D.L.; Alexander, H.R.; Thom, A.K. 1994: Use of tumor necrosis factor in isolated hepatic perfusion Circulatory Shock 44(1): 45-50
Arai, Y.; Kido, C.; Endo, T.; Aoki, T. 1987: Preliminary results of a phase Ii study of 5-FU, adriamycin, and mitomycin C (FAM) in combined hepatic infusion in patients with non-resectable metastatic liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(7): 2327-2333
Boija, P.O.; Nylander, G.; Ware, J. 1987: The effect of hemorrhagic stress on liver gluconeogenesis. An isolated rat liver perfusion study with three-carbon units as substrates Acta Chirurgica Scandinavica 153(4): 273-278